Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Area Cleaning

Analytics Overview

43
Form 483s Issued
8
483s converted to WL
45
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
04 Oct 2024
Avenue Pharmacy Inc dba Pathway Pharmacy
Drugs
27 Sep 2024
RC Outsourcing, LLC
Drugs
20 Sep 2024
Aarti Drugs Limited
Drugs
26 Jul 2024
Nubratori, Inc
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Yvins Dezan
3
0
Taichun Qin
3
1
Pratik S Upadhyay
3
0
Jolanna A Norton
2
0
Jessica P Mcalister
2
1
TITLE/ COMPANY Issue Date Status Details
Buildings used in the manufacturing of Intermediates and finished APIs are not maintained in a good state of repair.
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: Dirty AHU vents directly relate to inadequate area cleaning practices, essential for compliance.
Excerpt: AHU Vents were observed dirty, impacting production areas.
View Details
Contamination was observed in your production area and areas adjacent to production areas
Avenue Pharmacy Inc dba Pathway Pharmacy
04 Oct 2024 Normal Justification: Area Cleaning is relevant due to the observation of unclean surfaces and visible contaminants in critical areas.
Excerpt: White powder residue was observed on ALL surfaces (refrigerator, countertops, Bulk Drug Substance containers, etc.).
View Details
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.
RC Outsourcing, LLC
27 Sep 2024 Normal Justification: Critical area cleaning is essential for sterility; without thorough protocols, contamination risks increase.
Excerpt: Operators failed to clean wires used to connect UV lights near the ceiling inside the ISO 5 LAFW.
View Details
Written procedures are not established for cleaning of equipment and its subsequent release for use
Aarti Drugs Limited
20 Sep 2024 Normal Justification: Area Cleaning involves ensuring that post-cleaning, equipment is properly validated for cleanliness for the next use.
Excerpt: Written procedures are not established for cleaning of equipment and its subsequent release for use.
View Details
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.
Nubratori, Inc
26 Jul 2024 Normal Justification: Observation indicates critical lapses in the cleaning of areas meant to maintain aseptic conditions.
Excerpt: I observed that the operator failed to wipe down the ISO 7 side
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.